Table of Content


List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Arrhythmias - Overview
Arrhythmias - Therapeutics Development
Pipeline Overview
Pipeline by Companies
Pipeline by Universities/Institutes
Products under Development by Companies
Products under Development by Universities/Institutes
Arrhythmias - Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Arrhythmias - Companies Involved in Therapeutics Development
Academic Pharmaceuticals Inc
Aetas Pharma Co Ltd
Armgo Pharma Inc
BlueRock Therapeutics
Cardurion Pharmaceuticals LLC
Cyta Therapeutics Ltd
Espero BioPharma Inc
Galectin Therapeutics Inc
Gilead Sciences Inc
LATITUDE Pharmaceuticals Inc
Les Laboratoires Servier SAS
LQT Therapeutics Inc
OMEICOS Therapeutics GmbH
Orion Corp
SignPath Pharma Inc
Trucode Gene Repair Inc
Arrhythmias - Drug Profiles
amiodarone - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Antisense Oligonucleotides to Activate hERG1 for Arrhythmias - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
belapectin - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
CYP-002 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
efsevin - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
ESP-001 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
GS-680 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
GS-967 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
KN-93 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
M-201 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
MC-450 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Oligonucleotides to Activate KCNH2 for Arrhythmias - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
OMT-28 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
ORM-10103 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
PP-1 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Recombint Protein for Myocardial Infarction and Ventricular Arrhythmia - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Small Molecules 1 for Arrhythmia - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Small Molecules for Arrhythmia - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Small Molecules for Arrhythmias - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Small Molecules to Antagonize RyR2 for Heart Failure and Arrhythmias - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Small Molecules to Block KCa3.1 for Arrhythmias - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Small Molecules to Inhibit FKBP1A for Cardiovascular Diseases - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Small Molecules To Inhibit SGK-1 for Long QT Syndrome - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
soestelol - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
SPP-4040 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Stem Cell Therapy for Arrhythmias - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Arrhythmias - Dormant Projects
Arrhythmias - Discontinued Products
Arrhythmias - Product Development Milestones
Featured News & Press Releases
Sep 27, 2017: U.S. Patent Granted for Cyta Cymerus Technology
Sep 05, 2017: Cyta to Present at the 19th Annual Rodman & Renshaw Global Investment Conference in New York
Apr 19, 2017: Cyta Advances to Pre-IND Meeting with US FDA
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer



List of Figures


Number of Products under Development for Arrhythmias, H1 2020
Number of Products under Development by Companies, H1 2020
Number of Products under Development by Universities/Institutes, H1 2020
Number of Products by Top 10 Targets, H1 2020
Number of Products by Stage and Top 10 Targets, H1 2020
Number of Products by Top 10 Mechanism of Actions, H1 2020
Number of Products by Stage and Top 10 Mechanism of Actions, H1 2020
Number of Products by Routes of Administration, H1 2020
Number of Products by Stage and Routes of Administration, H1 2020
Number of Products by Molecule Types, H1 2020
Number of Products by Stage and Molecule Types, H1 2020


List of Tables


Number of Products under Development for Arrhythmias, H1 2020
Number of Products under Development by Companies, H1 2020
Number of Products under Development by Universities/Institutes, H1 2020
Products under Development by Companies, H1 2020
Products under Development by Universities/Institutes, H1 2020
Number of Products by Stage and Target, H1 2020
Number of Products by Stage and Mechanism of Action, H1 2020
Number of Products by Stage and Route of Administration, H1 2020
Number of Products by Stage and Molecule Type, H1 2020
Arrhythmias - Pipeline by Academic Pharmaceuticals Inc, H1 2020
Arrhythmias - Pipeline by Aetas Pharma Co Ltd, H1 2020
Arrhythmias - Pipeline by Armgo Pharma Inc, H1 2020
Arrhythmias - Pipeline by BlueRock Therapeutics, H1 2020
Arrhythmias - Pipeline by Cardurion Pharmaceuticals LLC, H1 2020
Arrhythmias - Pipeline by Cynata Therapeutics Ltd, H1 2020
Arrhythmias - Pipeline by Espero BioPharma Inc, H1 2020
Arrhythmias - Pipeline by Galectin Therapeutics Inc, H1 2020
Arrhythmias - Pipeline by Gilead Sciences Inc, H1 2020
Arrhythmias - Pipeline by LATITUDE Pharmaceuticals Inc, H1 2020
Arrhythmias - Pipeline by Les Laboratoires Servier SAS, H1 2020
Arrhythmias - Pipeline by LQT Therapeutics Inc, H1 2020
Arrhythmias - Pipeline by OMEICOS Therapeutics GmbH, H1 2020
Arrhythmias - Pipeline by Orion Corp, H1 2020
Arrhythmias - Pipeline by SignPath Pharma Inc, H1 2020
Arrhythmias - Pipeline by Trucode Gene Repair Inc, H1 2020
Arrhythmias - Dormant Projects, H1 2020
Arrhythmias - Dormant Projects, H1 2020 (Contd..1), H1 2020
Arrhythmias - Discontinued Products, H1 2020